nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB11—Cyclosporine—psoriasis	0.0716	0.102	CbGbCtD
Chlorpromazine—ALB—Acitretin—psoriasis	0.0661	0.0941	CbGbCtD
Chlorpromazine—BCHE—Triamcinolone—psoriasis	0.0638	0.0908	CbGbCtD
Chlorpromazine—CYP1A2—Clobetasol propionate—psoriasis	0.0614	0.0874	CbGbCtD
Chlorpromazine—ABCB11—Dexamethasone—psoriasis	0.0471	0.0671	CbGbCtD
Chlorpromazine—CYP1A2—Methoxsalen—psoriasis	0.0322	0.0459	CbGbCtD
Chlorpromazine—ALB—Mycophenolate mofetil—psoriasis	0.031	0.0441	CbGbCtD
Chlorpromazine—CYP2D6—Hydroxyurea—psoriasis	0.029	0.0414	CbGbCtD
Chlorpromazine—ALB—Prednisone—psoriasis	0.0247	0.0352	CbGbCtD
Chlorpromazine—CYP3A4—Calcitriol—psoriasis	0.0217	0.0309	CbGbCtD
Chlorpromazine—CYP2D6—Cholecalciferol—psoriasis	0.0176	0.0251	CbGbCtD
Chlorpromazine—CYP3A4—Methoxsalen—psoriasis	0.0169	0.0241	CbGbCtD
Chlorpromazine—ABCB1—Mycophenolate mofetil—psoriasis	0.0162	0.0231	CbGbCtD
Chlorpromazine—CYP2E1—Dexamethasone—psoriasis	0.016	0.0228	CbGbCtD
Chlorpromazine—ABCB1—Betamethasone—psoriasis	0.0139	0.0198	CbGbCtD
Chlorpromazine—ABCB1—Prednisolone—psoriasis	0.0137	0.0195	CbGbCtD
Chlorpromazine—ABCB1—Hydrocortisone—psoriasis	0.013	0.0185	CbGbCtD
Chlorpromazine—ABCB1—Prednisone—psoriasis	0.0129	0.0184	CbGbCtD
Chlorpromazine—ALB—Methotrexate—psoriasis	0.0124	0.0177	CbGbCtD
Chlorpromazine—ABCB1—Cyclosporine—psoriasis	0.0123	0.0175	CbGbCtD
Chlorpromazine—CYP2D6—Cyclosporine—psoriasis	0.0116	0.0165	CbGbCtD
Chlorpromazine—CYP3A4—Cholecalciferol—psoriasis	0.0112	0.0159	CbGbCtD
Chlorpromazine—CYP3A4—Triamcinolone—psoriasis	0.0097	0.0138	CbGbCtD
Chlorpromazine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0097	0.0138	CbGbCtD
Chlorpromazine—CYP3A4—Betamethasone—psoriasis	0.00832	0.0119	CbGbCtD
Chlorpromazine—CYP3A4—Prednisolone—psoriasis	0.00821	0.0117	CbGbCtD
Chlorpromazine—ABCB1—Dexamethasone—psoriasis	0.00808	0.0115	CbGbCtD
Chlorpromazine—CYP3A4—Hydrocortisone—psoriasis	0.00779	0.0111	CbGbCtD
Chlorpromazine—CYP3A4—Prednisone—psoriasis	0.00776	0.011	CbGbCtD
Chlorpromazine—CYP2D6—Dexamethasone—psoriasis	0.00761	0.0108	CbGbCtD
Chlorpromazine—CYP3A4—Cyclosporine—psoriasis	0.00735	0.0105	CbGbCtD
Chlorpromazine—ABCB1—Methotrexate—psoriasis	0.00649	0.00925	CbGbCtD
Chlorpromazine—CYP3A4—Dexamethasone—psoriasis	0.00484	0.00689	CbGbCtD
Chlorpromazine—Hypersensitivity—Fluocinonide—psoriasis	0.00059	0.0032	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Mycophenolate mofetil—psoriasis	0.000586	0.00318	CcSEcCtD
Chlorpromazine—Influenza—Mycophenolic acid—psoriasis	0.00058	0.00314	CcSEcCtD
Chlorpromazine—Asthma—Mycophenolic acid—psoriasis	0.00058	0.00314	CcSEcCtD
Chlorpromazine—Dysphagia—Mycophenolic acid—psoriasis	0.00058	0.00314	CcSEcCtD
Chlorpromazine—Dry mouth—Calcitriol—psoriasis	0.000575	0.00312	CcSEcCtD
Chlorpromazine—Insomnia—Methoxsalen—psoriasis	0.000572	0.0031	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Calcitriol—psoriasis	0.000563	0.00306	CcSEcCtD
Chlorpromazine—Amenorrhoea—Prednisone—psoriasis	0.000562	0.00305	CcSEcCtD
Chlorpromazine—Angioedema—Acitretin—psoriasis	0.000561	0.00304	CcSEcCtD
Chlorpromazine—Dermatitis contact—Betamethasone—psoriasis	0.000561	0.00304	CcSEcCtD
Chlorpromazine—Dermatitis contact—Dexamethasone—psoriasis	0.000561	0.00304	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Cyclosporine—psoriasis	0.00056	0.00304	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Cyclosporine—psoriasis	0.000556	0.00301	CcSEcCtD
Chlorpromazine—Pancytopenia—Mycophenolic acid—psoriasis	0.00055	0.00299	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.000542	0.00294	CcSEcCtD
Chlorpromazine—Cough—Acitretin—psoriasis	0.000536	0.00291	CcSEcCtD
Chlorpromazine—Dizziness—Beclomethasone—psoriasis	0.000534	0.0029	CcSEcCtD
Chlorpromazine—Cough—Fluocinolone Acetonide—psoriasis	0.000534	0.0029	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Mycophenolic acid—psoriasis	0.000534	0.0029	CcSEcCtD
Chlorpromazine—Dizziness—Fluocinonide—psoriasis	0.00053	0.00287	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Mycophenolic acid—psoriasis	0.000523	0.00284	CcSEcCtD
Chlorpromazine—Dry mouth—Acitretin—psoriasis	0.000511	0.00277	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Prednisolone—psoriasis	0.00051	0.00277	CcSEcCtD
Chlorpromazine—Insomnia—Calcitriol—psoriasis	0.00051	0.00276	CcSEcCtD
Chlorpromazine—Jaundice—Mycophenolic acid—psoriasis	0.000504	0.00273	CcSEcCtD
Chlorpromazine—Cardiac arrest—Mycophenolate mofetil—psoriasis	0.000503	0.00273	CcSEcCtD
Chlorpromazine—Urinary retention—Mycophenolate mofetil—psoriasis	0.000503	0.00273	CcSEcCtD
Chlorpromazine—Somnolence—Calcitriol—psoriasis	0.000501	0.00272	CcSEcCtD
Chlorpromazine—Body temperature increased—Methoxsalen—psoriasis	0.0005	0.00271	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.000498	0.0027	CcSEcCtD
Chlorpromazine—Infection—Acitretin—psoriasis	0.000498	0.0027	CcSEcCtD
Chlorpromazine—Infection—Fluocinolone Acetonide—psoriasis	0.000497	0.00269	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Mycophenolate mofetil—psoriasis	0.000483	0.00262	CcSEcCtD
Chlorpromazine—Agranulocytosis—Mycophenolic acid—psoriasis	0.000482	0.00262	CcSEcCtD
Chlorpromazine—Constipation—Calcitriol—psoriasis	0.000482	0.00261	CcSEcCtD
Chlorpromazine—Cardiac arrest—Prednisolone—psoriasis	0.000469	0.00255	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Triamcinolone—psoriasis	0.000469	0.00254	CcSEcCtD
Chlorpromazine—Dysphagia—Cyclosporine—psoriasis	0.000469	0.00254	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methoxsalen—psoriasis	0.000466	0.00253	CcSEcCtD
Chlorpromazine—Cardiac arrest—Hydrocortisone—psoriasis	0.000458	0.00249	CcSEcCtD
Chlorpromazine—Asthma—Mycophenolate mofetil—psoriasis	0.000457	0.00248	CcSEcCtD
Chlorpromazine—Dysphagia—Mycophenolate mofetil—psoriasis	0.000457	0.00248	CcSEcCtD
Chlorpromazine—Influenza—Mycophenolate mofetil—psoriasis	0.000457	0.00248	CcSEcCtD
Chlorpromazine—Oedema peripheral—Mycophenolic acid—psoriasis	0.000457	0.00248	CcSEcCtD
Chlorpromazine—Insomnia—Acitretin—psoriasis	0.000453	0.00246	CcSEcCtD
Chlorpromazine—Visual impairment—Mycophenolic acid—psoriasis	0.000447	0.00242	CcSEcCtD
Chlorpromazine—Somnolence—Acitretin—psoriasis	0.000446	0.00242	CcSEcCtD
Chlorpromazine—Body temperature increased—Calcitriol—psoriasis	0.000445	0.00242	CcSEcCtD
Chlorpromazine—Pancytopenia—Mycophenolate mofetil—psoriasis	0.000434	0.00236	CcSEcCtD
Chlorpromazine—Cardiac arrest—Triamcinolone—psoriasis	0.000432	0.00234	CcSEcCtD
Chlorpromazine—Leukopenia—Hydroxyurea—psoriasis	0.000432	0.00234	CcSEcCtD
Chlorpromazine—Constipation—Acitretin—psoriasis	0.000429	0.00232	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Dexamethasone—psoriasis	0.000426	0.00231	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Betamethasone—psoriasis	0.000426	0.00231	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Cyclosporine—psoriasis	0.000423	0.00229	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Mycophenolate mofetil—psoriasis	0.000421	0.00228	CcSEcCtD
Chlorpromazine—Dizziness—Methoxsalen—psoriasis	0.000418	0.00227	CcSEcCtD
Chlorpromazine—Convulsion—Hydroxyurea—psoriasis	0.000418	0.00227	CcSEcCtD
Chlorpromazine—Hypersensitivity—Calcitriol—psoriasis	0.000415	0.00225	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Mycophenolate mofetil—psoriasis	0.000413	0.00224	CcSEcCtD
Chlorpromazine—Jaundice—Cyclosporine—psoriasis	0.000407	0.00221	CcSEcCtD
Chlorpromazine—Jaundice—Mycophenolate mofetil—psoriasis	0.000398	0.00216	CcSEcCtD
Chlorpromazine—Body temperature increased—Acitretin—psoriasis	0.000396	0.00215	CcSEcCtD
Chlorpromazine—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000395	0.00214	CcSEcCtD
Chlorpromazine—Influenza—Triamcinolone—psoriasis	0.000392	0.00213	CcSEcCtD
Chlorpromazine—Asthma—Triamcinolone—psoriasis	0.000392	0.00213	CcSEcCtD
Chlorpromazine—Nervousness—Mycophenolic acid—psoriasis	0.000392	0.00213	CcSEcCtD
Chlorpromazine—Cardiac arrest—Betamethasone—psoriasis	0.000392	0.00212	CcSEcCtD
Chlorpromazine—Cardiac arrest—Dexamethasone—psoriasis	0.000392	0.00212	CcSEcCtD
Chlorpromazine—Infection—Hydroxyurea—psoriasis	0.000391	0.00212	CcSEcCtD
Chlorpromazine—Muscle spasms—Mycophenolic acid—psoriasis	0.000388	0.00211	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Methotrexate—psoriasis	0.000388	0.0021	CcSEcCtD
Chlorpromazine—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000381	0.00206	CcSEcCtD
Chlorpromazine—Tremor—Mycophenolic acid—psoriasis	0.000378	0.00205	CcSEcCtD
Chlorpromazine—Gynaecomastia—Methotrexate—psoriasis	0.00037	0.002	CcSEcCtD
Chlorpromazine—Hypersensitivity—Acitretin—psoriasis	0.000369	0.002	CcSEcCtD
Chlorpromazine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000368	0.002	CcSEcCtD
Chlorpromazine—Syncope—Mycophenolic acid—psoriasis	0.000362	0.00196	CcSEcCtD
Chlorpromazine—Visual impairment—Cyclosporine—psoriasis	0.000362	0.00196	CcSEcCtD
Chlorpromazine—Leukopenia—Mycophenolic acid—psoriasis	0.000361	0.00196	CcSEcCtD
Chlorpromazine—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000361	0.00196	CcSEcCtD
Chlorpromazine—Loss of consciousness—Mycophenolic acid—psoriasis	0.000355	0.00193	CcSEcCtD
Chlorpromazine—Visual impairment—Mycophenolate mofetil—psoriasis	0.000353	0.00191	CcSEcCtD
Chlorpromazine—Cough—Mycophenolic acid—psoriasis	0.000352	0.00191	CcSEcCtD
Chlorpromazine—Dyspnoea—Hydroxyurea—psoriasis	0.000351	0.0019	CcSEcCtD
Chlorpromazine—Convulsion—Mycophenolic acid—psoriasis	0.00035	0.0019	CcSEcCtD
Chlorpromazine—Somnolence—Hydroxyurea—psoriasis	0.00035	0.0019	CcSEcCtD
Chlorpromazine—Photosensitivity—Methotrexate—psoriasis	0.000341	0.00185	CcSEcCtD
Chlorpromazine—Cardiac arrest—Prednisone—psoriasis	0.000341	0.00185	CcSEcCtD
Chlorpromazine—Constipation—Hydroxyurea—psoriasis	0.000336	0.00183	CcSEcCtD
Chlorpromazine—Dry mouth—Mycophenolic acid—psoriasis	0.000336	0.00182	CcSEcCtD
Chlorpromazine—Dizziness—Acitretin—psoriasis	0.000331	0.0018	CcSEcCtD
Chlorpromazine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000331	0.00179	CcSEcCtD
Chlorpromazine—Visual impairment—Prednisolone—psoriasis	0.000329	0.00178	CcSEcCtD
Chlorpromazine—Infection—Mycophenolic acid—psoriasis	0.000327	0.00178	CcSEcCtD
Chlorpromazine—Shock—Mycophenolic acid—psoriasis	0.000324	0.00176	CcSEcCtD
Chlorpromazine—Tachycardia—Mycophenolic acid—psoriasis	0.000322	0.00174	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Betamethasone—psoriasis	0.000321	0.00174	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Dexamethasone—psoriasis	0.000321	0.00174	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000318	0.00172	CcSEcCtD
Chlorpromazine—Nervousness—Cyclosporine—psoriasis	0.000317	0.00172	CcSEcCtD
Chlorpromazine—Muscle spasms—Cyclosporine—psoriasis	0.000314	0.0017	CcSEcCtD
Chlorpromazine—Body temperature increased—Hydroxyurea—psoriasis	0.000311	0.00169	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—psoriasis	0.00031	0.00168	CcSEcCtD
Chlorpromazine—Nervousness—Mycophenolate mofetil—psoriasis	0.00031	0.00168	CcSEcCtD
Chlorpromazine—Hypotension—Mycophenolic acid—psoriasis	0.000308	0.00167	CcSEcCtD
Chlorpromazine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000306	0.00166	CcSEcCtD
Chlorpromazine—Tremor—Cyclosporine—psoriasis	0.000306	0.00166	CcSEcCtD
Chlorpromazine—Tremor—Mycophenolate mofetil—psoriasis	0.000299	0.00162	CcSEcCtD
Chlorpromazine—Angioedema—Cyclosporine—psoriasis	0.000299	0.00162	CcSEcCtD
Chlorpromazine—Insomnia—Mycophenolic acid—psoriasis	0.000298	0.00162	CcSEcCtD
Chlorpromazine—Dyspnoea—Mycophenolic acid—psoriasis	0.000294	0.00159	CcSEcCtD
Chlorpromazine—Somnolence—Mycophenolic acid—psoriasis	0.000293	0.00159	CcSEcCtD
Chlorpromazine—Leukopenia—Cyclosporine—psoriasis	0.000292	0.00159	CcSEcCtD
Chlorpromazine—Angioedema—Mycophenolate mofetil—psoriasis	0.000291	0.00158	CcSEcCtD
Chlorpromazine—Hypersensitivity—Hydroxyurea—psoriasis	0.00029	0.00157	CcSEcCtD
Chlorpromazine—Syncope—Mycophenolate mofetil—psoriasis	0.000286	0.00155	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Prednisone—psoriasis	0.000286	0.00155	CcSEcCtD
Chlorpromazine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000285	0.00155	CcSEcCtD
Chlorpromazine—Cough—Cyclosporine—psoriasis	0.000285	0.00155	CcSEcCtD
Chlorpromazine—Convulsion—Cyclosporine—psoriasis	0.000283	0.00154	CcSEcCtD
Chlorpromazine—Constipation—Mycophenolic acid—psoriasis	0.000282	0.00153	CcSEcCtD
Chlorpromazine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00028	0.00152	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Prednisone—psoriasis	0.00028	0.00152	CcSEcCtD
Chlorpromazine—Cough—Mycophenolate mofetil—psoriasis	0.000278	0.00151	CcSEcCtD
Chlorpromazine—Convulsion—Mycophenolate mofetil—psoriasis	0.000276	0.0015	CcSEcCtD
Chlorpromazine—Visual impairment—Betamethasone—psoriasis	0.000275	0.00149	CcSEcCtD
Chlorpromazine—Visual impairment—Dexamethasone—psoriasis	0.000275	0.00149	CcSEcCtD
Chlorpromazine—Dry mouth—Cyclosporine—psoriasis	0.000272	0.00148	CcSEcCtD
Chlorpromazine—Angioedema—Prednisolone—psoriasis	0.000272	0.00147	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Cyclosporine—psoriasis	0.000267	0.00145	CcSEcCtD
Chlorpromazine—Syncope—Prednisolone—psoriasis	0.000267	0.00145	CcSEcCtD
Chlorpromazine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000265	0.00144	CcSEcCtD
Chlorpromazine—Angioedema—Hydrocortisone—psoriasis	0.000265	0.00144	CcSEcCtD
Chlorpromazine—Infection—Cyclosporine—psoriasis	0.000265	0.00144	CcSEcCtD
Chlorpromazine—Loss of consciousness—Prednisolone—psoriasis	0.000261	0.00142	CcSEcCtD
Chlorpromazine—Body temperature increased—Mycophenolic acid—psoriasis	0.000261	0.00141	CcSEcCtD
Chlorpromazine—Syncope—Hydrocortisone—psoriasis	0.00026	0.00141	CcSEcCtD
Chlorpromazine—Dizziness—Hydroxyurea—psoriasis	0.00026	0.00141	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00026	0.00141	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—psoriasis	0.000259	0.00141	CcSEcCtD
Chlorpromazine—Infection—Mycophenolate mofetil—psoriasis	0.000258	0.0014	CcSEcCtD
Chlorpromazine—Convulsion—Prednisolone—psoriasis	0.000258	0.0014	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—psoriasis	0.000257	0.00139	CcSEcCtD
Chlorpromazine—Shock—Mycophenolate mofetil—psoriasis	0.000256	0.00139	CcSEcCtD
Chlorpromazine—Loss of consciousness—Hydrocortisone—psoriasis	0.000255	0.00138	CcSEcCtD
Chlorpromazine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000254	0.00138	CcSEcCtD
Chlorpromazine—Convulsion—Hydrocortisone—psoriasis	0.000252	0.00136	CcSEcCtD
Chlorpromazine—Angioedema—Triamcinolone—psoriasis	0.00025	0.00135	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—psoriasis	0.000246	0.00133	CcSEcCtD
Chlorpromazine—Syncope—Triamcinolone—psoriasis	0.000245	0.00133	CcSEcCtD
Chlorpromazine—Hypotension—Mycophenolate mofetil—psoriasis	0.000243	0.00132	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Prednisolone—psoriasis	0.000243	0.00132	CcSEcCtD
Chlorpromazine—Insomnia—Cyclosporine—psoriasis	0.000241	0.00131	CcSEcCtD
Chlorpromazine—Loss of consciousness—Triamcinolone—psoriasis	0.00024	0.0013	CcSEcCtD
Chlorpromazine—Shock—Prednisolone—psoriasis	0.000239	0.00129	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—psoriasis	0.000239	0.00129	CcSEcCtD
Chlorpromazine—Cough—Triamcinolone—psoriasis	0.000239	0.00129	CcSEcCtD
Chlorpromazine—Dyspnoea—Cyclosporine—psoriasis	0.000238	0.00129	CcSEcCtD
Chlorpromazine—Somnolence—Cyclosporine—psoriasis	0.000237	0.00129	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000237	0.00129	CcSEcCtD
Chlorpromazine—Convulsion—Triamcinolone—psoriasis	0.000237	0.00128	CcSEcCtD
Chlorpromazine—Tachycardia—Prednisolone—psoriasis	0.000237	0.00128	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—psoriasis	0.000237	0.00128	CcSEcCtD
Chlorpromazine—Infection—Hydrocortisone—psoriasis	0.000235	0.00128	CcSEcCtD
Chlorpromazine—Insomnia—Mycophenolate mofetil—psoriasis	0.000235	0.00128	CcSEcCtD
Chlorpromazine—Shock—Hydrocortisone—psoriasis	0.000233	0.00126	CcSEcCtD
Chlorpromazine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000232	0.00126	CcSEcCtD
Chlorpromazine—Tachycardia—Hydrocortisone—psoriasis	0.000231	0.00125	CcSEcCtD
Chlorpromazine—Somnolence—Mycophenolate mofetil—psoriasis	0.000231	0.00125	CcSEcCtD
Chlorpromazine—Drowsiness—Methotrexate—psoriasis	0.000231	0.00125	CcSEcCtD
Chlorpromazine—Constipation—Cyclosporine—psoriasis	0.000228	0.00124	CcSEcCtD
Chlorpromazine—Dry mouth—Triamcinolone—psoriasis	0.000228	0.00123	CcSEcCtD
Chlorpromazine—Angioedema—Betamethasone—psoriasis	0.000227	0.00123	CcSEcCtD
Chlorpromazine—Angioedema—Dexamethasone—psoriasis	0.000227	0.00123	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Triamcinolone—psoriasis	0.000223	0.00121	CcSEcCtD
Chlorpromazine—Syncope—Betamethasone—psoriasis	0.000222	0.00121	CcSEcCtD
Chlorpromazine—Syncope—Dexamethasone—psoriasis	0.000222	0.00121	CcSEcCtD
Chlorpromazine—Constipation—Mycophenolate mofetil—psoriasis	0.000222	0.00121	CcSEcCtD
Chlorpromazine—Infection—Triamcinolone—psoriasis	0.000222	0.0012	CcSEcCtD
Chlorpromazine—Hypotension—Hydrocortisone—psoriasis	0.000221	0.0012	CcSEcCtD
Chlorpromazine—Shock—Triamcinolone—psoriasis	0.00022	0.00119	CcSEcCtD
Chlorpromazine—Insomnia—Prednisolone—psoriasis	0.000219	0.00119	CcSEcCtD
Chlorpromazine—Loss of consciousness—Dexamethasone—psoriasis	0.000218	0.00118	CcSEcCtD
Chlorpromazine—Loss of consciousness—Betamethasone—psoriasis	0.000218	0.00118	CcSEcCtD
Chlorpromazine—Dizziness—Mycophenolic acid—psoriasis	0.000218	0.00118	CcSEcCtD
Chlorpromazine—Tachycardia—Triamcinolone—psoriasis	0.000218	0.00118	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—psoriasis	0.000216	0.00117	CcSEcCtD
Chlorpromazine—Convulsion—Betamethasone—psoriasis	0.000215	0.00117	CcSEcCtD
Chlorpromazine—Convulsion—Dexamethasone—psoriasis	0.000215	0.00117	CcSEcCtD
Chlorpromazine—Insomnia—Hydrocortisone—psoriasis	0.000214	0.00116	CcSEcCtD
Chlorpromazine—Body temperature increased—Cyclosporine—psoriasis	0.000211	0.00114	CcSEcCtD
Chlorpromazine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000206	0.00112	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Betamethasone—psoriasis	0.000202	0.0011	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Dexamethasone—psoriasis	0.000202	0.0011	CcSEcCtD
Chlorpromazine—Insomnia—Triamcinolone—psoriasis	0.000202	0.00109	CcSEcCtD
Chlorpromazine—Infection—Dexamethasone—psoriasis	0.000201	0.00109	CcSEcCtD
Chlorpromazine—Infection—Betamethasone—psoriasis	0.000201	0.00109	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—psoriasis	0.0002	0.00108	CcSEcCtD
Chlorpromazine—Shock—Dexamethasone—psoriasis	0.000199	0.00108	CcSEcCtD
Chlorpromazine—Shock—Betamethasone—psoriasis	0.000199	0.00108	CcSEcCtD
Chlorpromazine—Dyspnoea—Triamcinolone—psoriasis	0.000199	0.00108	CcSEcCtD
Chlorpromazine—Tachycardia—Betamethasone—psoriasis	0.000198	0.00107	CcSEcCtD
Chlorpromazine—Tachycardia—Dexamethasone—psoriasis	0.000198	0.00107	CcSEcCtD
Chlorpromazine—Angioedema—Prednisone—psoriasis	0.000197	0.00107	CcSEcCtD
Chlorpromazine—Hypersensitivity—Cyclosporine—psoriasis	0.000196	0.00107	CcSEcCtD
Chlorpromazine—Syncope—Prednisone—psoriasis	0.000194	0.00105	CcSEcCtD
Chlorpromazine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000192	0.00104	CcSEcCtD
Chlorpromazine—Loss of consciousness—Prednisone—psoriasis	0.00019	0.00103	CcSEcCtD
Chlorpromazine—Hypotension—Dexamethasone—psoriasis	0.000189	0.00103	CcSEcCtD
Chlorpromazine—Hypotension—Betamethasone—psoriasis	0.000189	0.00103	CcSEcCtD
Chlorpromazine—Body temperature increased—Hydrocortisone—psoriasis	0.000187	0.00102	CcSEcCtD
Chlorpromazine—Convulsion—Prednisone—psoriasis	0.000187	0.00102	CcSEcCtD
Chlorpromazine—Insomnia—Dexamethasone—psoriasis	0.000183	0.000993	CcSEcCtD
Chlorpromazine—Insomnia—Betamethasone—psoriasis	0.000183	0.000993	CcSEcCtD
Chlorpromazine—Hypersensitivity—Prednisolone—psoriasis	0.000179	0.00097	CcSEcCtD
Chlorpromazine—Body temperature increased—Triamcinolone—psoriasis	0.000176	0.000957	CcSEcCtD
Chlorpromazine—Dizziness—Cyclosporine—psoriasis	0.000176	0.000956	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Prednisone—psoriasis	0.000176	0.000956	CcSEcCtD
Chlorpromazine—Infection—Prednisone—psoriasis	0.000175	0.00095	CcSEcCtD
Chlorpromazine—Hypersensitivity—Hydrocortisone—psoriasis	0.000175	0.000947	CcSEcCtD
Chlorpromazine—Shock—Prednisone—psoriasis	0.000173	0.000941	CcSEcCtD
Chlorpromazine—Tachycardia—Prednisone—psoriasis	0.000172	0.000933	CcSEcCtD
Chlorpromazine—Dizziness—Mycophenolate mofetil—psoriasis	0.000172	0.000933	CcSEcCtD
Chlorpromazine—Hypersensitivity—Triamcinolone—psoriasis	0.000164	0.000892	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—psoriasis	0.000162	0.000877	CcSEcCtD
Chlorpromazine—Dizziness—Prednisolone—psoriasis	0.00016	0.00087	CcSEcCtD
Chlorpromazine—Body temperature increased—Dexamethasone—psoriasis	0.00016	0.000868	CcSEcCtD
Chlorpromazine—Body temperature increased—Betamethasone—psoriasis	0.00016	0.000868	CcSEcCtD
Chlorpromazine—Insomnia—Prednisone—psoriasis	0.000159	0.000865	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—psoriasis	0.000158	0.000854	CcSEcCtD
Chlorpromazine—Dizziness—Hydrocortisone—psoriasis	0.000157	0.00085	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—psoriasis	0.000156	0.000848	CcSEcCtD
Chlorpromazine—Constipation—Prednisone—psoriasis	0.000151	0.000818	CcSEcCtD
Chlorpromazine—Dizziness—Triamcinolone—psoriasis	0.000148	0.0008	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—psoriasis	0.000147	0.000799	CcSEcCtD
Chlorpromazine—Infection—Methotrexate—psoriasis	0.000146	0.000794	CcSEcCtD
Chlorpromazine—Body temperature increased—Prednisone—psoriasis	0.000139	0.000756	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—psoriasis	0.000138	0.000747	CcSEcCtD
Chlorpromazine—Dizziness—Betamethasone—psoriasis	0.000134	0.000726	CcSEcCtD
Chlorpromazine—Dizziness—Dexamethasone—psoriasis	0.000134	0.000726	CcSEcCtD
Chlorpromazine—Insomnia—Methotrexate—psoriasis	0.000133	0.000723	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—psoriasis	0.000131	0.000712	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—psoriasis	0.000131	0.00071	CcSEcCtD
Chlorpromazine—Hypersensitivity—Prednisone—psoriasis	0.00013	0.000705	CcSEcCtD
Chlorpromazine—Dizziness—Prednisone—psoriasis	0.000117	0.000632	CcSEcCtD
Chlorpromazine—Body temperature increased—Methotrexate—psoriasis	0.000116	0.000632	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—psoriasis	0.000109	0.000589	CcSEcCtD
Chlorpromazine—Dizziness—Methotrexate—psoriasis	9.74e-05	0.000528	CcSEcCtD
Chlorpromazine—CALM2—Hemostasis—TP53—psoriasis	9.62e-06	8.49e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—TP53—psoriasis	9.62e-06	8.49e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—JUN—psoriasis	9.61e-06	8.48e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—APOE—psoriasis	9.56e-06	8.44e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—APOE—psoriasis	9.56e-06	8.44e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—CXCL8—psoriasis	9.45e-06	8.34e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—TYK2—psoriasis	9.44e-06	8.33e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—TYK2—psoriasis	9.44e-06	8.33e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PPARG—psoriasis	9.44e-06	8.33e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	9.43e-06	8.32e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—IL6—psoriasis	9.41e-06	8.31e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—CXCL8—psoriasis	9.3e-06	8.21e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	9.28e-06	8.19e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—NFKB1—psoriasis	9.26e-06	8.17e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NFKBIA—psoriasis	9.26e-06	8.17e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—NFKB1—psoriasis	9.25e-06	8.17e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	9.23e-06	8.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	9.2e-06	8.12e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—JUN—psoriasis	9.2e-06	8.12e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IFNG—psoriasis	9.14e-06	8.07e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	9.11e-06	8.04e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—CAT—psoriasis	9.09e-06	8.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	9.09e-06	8.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—LEP—psoriasis	9.06e-06	8e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—APOE—psoriasis	9.06e-06	8e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—TYK2—psoriasis	9.01e-06	7.95e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—CXCL8—psoriasis	9e-06	7.94e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—CXCL8—psoriasis	9e-06	7.94e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—IL6—psoriasis	8.98e-06	7.93e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—CXCL8—psoriasis	8.91e-06	7.86e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—NFKB1—psoriasis	8.86e-06	7.82e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IFNG—psoriasis	8.84e-06	7.8e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IFNG—psoriasis	8.84e-06	7.8e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD4—psoriasis	8.83e-06	7.79e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TYK2—psoriasis	8.8e-06	7.77e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—CXCL8—psoriasis	8.79e-06	7.76e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—JUN—psoriasis	8.78e-06	7.75e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TYK2—psoriasis	8.75e-06	7.73e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—TYK2—psoriasis	8.72e-06	7.69e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—TYK2—psoriasis	8.72e-06	7.69e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PPARG—psoriasis	8.67e-06	7.65e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PPARG—psoriasis	8.61e-06	7.6e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—TP53—psoriasis	8.6e-06	7.59e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—APOE—psoriasis	8.55e-06	7.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD4—psoriasis	8.54e-06	7.54e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD4—psoriasis	8.54e-06	7.54e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—IL6—psoriasis	8.47e-06	7.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—NFKB1—psoriasis	8.45e-06	7.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	8.44e-06	7.45e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—VEGFA—psoriasis	8.41e-06	7.42e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—VEGFA—psoriasis	8.4e-06	7.41e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TYK2—psoriasis	8.38e-06	7.4e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—IL6—psoriasis	8.36e-06	7.38e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PPARG—psoriasis	8.33e-06	7.35e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PPARG—psoriasis	8.33e-06	7.35e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—STAT3—psoriasis	8.32e-06	7.35e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—STAT3—psoriasis	8.31e-06	7.34e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—JUN—psoriasis	8.28e-06	7.31e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—LEP—psoriasis	8.27e-06	7.3e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—APOE—psoriasis	8.27e-06	7.3e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—TP53—psoriasis	8.23e-06	7.26e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—IL6—psoriasis	8.2e-06	7.23e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—JUN—psoriasis	8.17e-06	7.21e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—CD4—psoriasis	8.15e-06	7.19e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—VEGFA—psoriasis	8.04e-06	7.09e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—APOE—psoriasis	8e-06	7.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—LEP—psoriasis	8e-06	7.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—APOE—psoriasis	8e-06	7.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—LEP—psoriasis	8e-06	7.06e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—NFKB1—psoriasis	7.97e-06	7.04e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—STAT3—psoriasis	7.96e-06	7.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—IL6—psoriasis	7.93e-06	7e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—IL6—psoriasis	7.93e-06	7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—JUN—psoriasis	7.9e-06	6.97e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—CD4—psoriasis	7.88e-06	6.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—CD4—psoriasis	7.88e-06	6.96e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—NFKB1—psoriasis	7.87e-06	6.94e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TYK2—psoriasis	7.73e-06	6.82e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NFKBIA—psoriasis	7.7e-06	6.8e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CAT—psoriasis	7.7e-06	6.79e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—VEGFA—psoriasis	7.67e-06	6.77e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.66e-06	6.76e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—JUN—psoriasis	7.64e-06	6.74e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—JUN—psoriasis	7.64e-06	6.74e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CXCL8—psoriasis	7.62e-06	6.73e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—NFKB1—psoriasis	7.6e-06	6.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TYK2—psoriasis	7.6e-06	6.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—STAT3—psoriasis	7.6e-06	6.71e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TYK2—psoriasis	7.58e-06	6.69e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TYK2—psoriasis	7.56e-06	6.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TYK2—psoriasis	7.54e-06	6.65e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—IL6—psoriasis	7.53e-06	6.65e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—APOE—psoriasis	7.49e-06	6.61e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TYK2—psoriasis	7.46e-06	6.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NFKBIA—psoriasis	7.45e-06	6.58e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NFKBIA—psoriasis	7.45e-06	6.58e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PPARG—psoriasis	7.45e-06	6.57e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TYK2—psoriasis	7.44e-06	6.57e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—NFKB1—psoriasis	7.36e-06	6.49e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—NFKB1—psoriasis	7.36e-06	6.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	7.3e-06	6.44e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—IL6—psoriasis	7.28e-06	6.43e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—IL6—psoriasis	7.25e-06	6.4e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—VEGFA—psoriasis	7.24e-06	6.39e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—STAT3—psoriasis	7.16e-06	6.32e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—VEGFA—psoriasis	7.14e-06	6.3e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—JUN—psoriasis	7.12e-06	6.29e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—JUN—psoriasis	7.09e-06	6.25e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—STAT3—psoriasis	7.07e-06	6.24e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—APOE—psoriasis	7.06e-06	6.23e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.94e-06	6.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.92e-06	6.1e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.86e-06	6.05e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—STAT3—psoriasis	6.83e-06	6.03e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—NFKB1—psoriasis	6.82e-06	6.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—JUN—psoriasis	6.78e-06	5.99e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CXCL8—psoriasis	6.73e-06	5.94e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.62e-06	5.84e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—STAT3—psoriasis	6.61e-06	5.83e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—STAT3—psoriasis	6.61e-06	5.83e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CXCL8—psoriasis	6.6e-06	5.83e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CXCL8—psoriasis	6.58e-06	5.81e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CXCL8—psoriasis	6.56e-06	5.79e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.53e-06	5.76e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PPARG—psoriasis	6.53e-06	5.76e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CXCL8—psoriasis	6.5e-06	5.74e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	6.48e-06	5.72e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—IL6—psoriasis	6.4e-06	5.65e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—psoriasis	6.35e-06	5.61e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—psoriasis	6.34e-06	5.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TYK2—psoriasis	6.31e-06	5.57e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—STAT3—psoriasis	6.31e-06	5.57e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—IL6—psoriasis	6.29e-06	5.55e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—IL6—psoriasis	6.28e-06	5.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—IL6—psoriasis	6.26e-06	5.53e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—JUN—psoriasis	6.25e-06	5.52e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—IL6—psoriasis	6.24e-06	5.51e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	6.22e-06	5.49e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—psoriasis	6.19e-06	5.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—IL6—psoriasis	6.18e-06	5.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—IL6—psoriasis	6.16e-06	5.44e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—STAT3—psoriasis	6.16e-06	5.44e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—JUN—psoriasis	6.15e-06	5.43e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PPARG—psoriasis	6.15e-06	5.43e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—JUN—psoriasis	6.14e-06	5.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—STAT3—psoriasis	6.13e-06	5.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—JUN—psoriasis	6.12e-06	5.4e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TYK2—psoriasis	6.1e-06	5.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TYK2—psoriasis	6.1e-06	5.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—STAT3—psoriasis	6.1e-06	5.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—STAT3—psoriasis	6.1e-06	5.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—JUN—psoriasis	6.1e-06	5.38e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—psoriasis	6.07e-06	5.36e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—JUN—psoriasis	6.04e-06	5.33e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—JUN—psoriasis	6.02e-06	5.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	6.02e-06	5.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NFKB1—psoriasis	6.02e-06	5.31e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—APOE—psoriasis	5.98e-06	5.28e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CAT—psoriasis	5.94e-06	5.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.93e-06	5.23e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.92e-06	5.23e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NFKB1—psoriasis	5.91e-06	5.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NFKB1—psoriasis	5.89e-06	5.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NFKB1—psoriasis	5.87e-06	5.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.87e-06	5.18e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.82e-06	5.13e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—IL6—psoriasis	5.81e-06	5.13e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—IL6—psoriasis	5.81e-06	5.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.8e-06	5.12e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—psoriasis	5.8e-06	5.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—IL6—psoriasis	5.73e-06	5.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—JUN—psoriasis	5.6e-06	4.94e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—IL6—psoriasis	5.56e-06	4.91e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CXCL8—psoriasis	5.49e-06	4.85e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—psoriasis	5.47e-06	4.83e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.46e-06	4.82e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—STAT3—psoriasis	5.41e-06	4.77e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—psoriasis	5.39e-06	4.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.39e-06	4.76e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.38e-06	4.74e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—psoriasis	5.36e-06	4.73e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—psoriasis	5.35e-06	4.72e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—psoriasis	5.33e-06	4.7e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.32e-06	4.7e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CXCL8—psoriasis	5.31e-06	4.69e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CXCL8—psoriasis	5.31e-06	4.69e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—STAT3—psoriasis	5.31e-06	4.69e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—IL6—psoriasis	5.31e-06	4.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STAT3—psoriasis	5.29e-06	4.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.28e-06	4.66e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STAT3—psoriasis	5.28e-06	4.66e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5.26e-06	4.65e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STAT3—psoriasis	5.23e-06	4.61e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—IL6—psoriasis	5.22e-06	4.61e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STAT3—psoriasis	5.21e-06	4.6e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—psoriasis	5.21e-06	4.6e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—JUN—psoriasis	5.11e-06	4.51e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—IL6—psoriasis	5.05e-06	4.46e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—IL6—psoriasis	5.05e-06	4.46e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IL6—psoriasis	5e-06	4.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—JUN—psoriasis	4.94e-06	4.36e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—JUN—psoriasis	4.94e-06	4.36e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IL6—psoriasis	4.94e-06	4.36e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NFKB1—psoriasis	4.92e-06	4.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.89e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.84e-06	4.27e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL6—psoriasis	4.77e-06	4.21e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NFKB1—psoriasis	4.76e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NFKB1—psoriasis	4.76e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—psoriasis	4.7e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—psoriasis	4.68e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL6—psoriasis	4.62e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL6—psoriasis	4.62e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOE—psoriasis	4.62e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—psoriasis	4.48e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—psoriasis	4.46e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STAT3—psoriasis	4.42e-06	3.9e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—IL6—psoriasis	4.41e-06	3.89e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—psoriasis	4.32e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—psoriasis	4.32e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IL6—psoriasis	4.3e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IL6—psoriasis	4.28e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STAT3—psoriasis	4.27e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STAT3—psoriasis	4.27e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—IL6—psoriasis	4.26e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—IL6—psoriasis	4.26e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—psoriasis	4.13e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IL6—psoriasis	4.1e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—psoriasis	4.06e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—psoriasis	4.05e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—psoriasis	4.04e-06	3.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—psoriasis	4.03e-06	3.55e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—psoriasis	4.02e-06	3.55e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—psoriasis	3.99e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.98e-06	3.51e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL6—psoriasis	3.78e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL6—psoriasis	3.72e-06	3.28e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL6—psoriasis	3.71e-06	3.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL6—psoriasis	3.7e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.7e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL6—psoriasis	3.69e-06	3.25e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL6—psoriasis	3.65e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.64e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.38e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—psoriasis	3.37e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—psoriasis	3.26e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—psoriasis	3.26e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL6—psoriasis	3.09e-06	2.72e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL6—psoriasis	2.99e-06	2.63e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL6—psoriasis	2.99e-06	2.63e-05	CbGpPWpGaD
